Target Details
| UniProt AC | P22607 |
|---|---|
| Gene Symbol | FGFR3 |
| Protein Name | Fibroblast growth factor receptor 3 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF21165 (FGFR3_TM) PF07679 (I-set) PF13927 (Ig_3) PF07714 (PK_Tyr_Ser-Thr) |
Summary
- Multi-target molecules 2,742
- Clinical molecules 64
- Avg pChEMBL 7.75
KEGG Pathways (13)
- Bladder cancer
- Calcium signaling pathway
- Central carbon metabolism in cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocytosis
- MAPK signaling pathway
- MicroRNAs in cancer
- PI3K-Akt signaling pathway
- Pathways in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Signaling pathways regulating pluripotency of stem cells
Associated Diseases (15)
- Achondroplasia
- Bladder cancer
- CATSHL syndrome
- Colorectal cancer
- Crouzon syndrome
- Epidermal nevus
- FGFR3-related short limb skeletal dysplasia
- Hypochondroplasia
- Lacrimo-auriculo-dento-digital syndrome
- Muenke syndrome
- Multiple myeloma
- SADDAN
- Syndromic craniosynostoses
- Testicular cancer
- Thanatophoric dysplasia
Active Molecules (2,742)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
BNZAPGUSNOSNGF
|
9.0 | IC50 | 2 | — | |
HAOZVAGRAFPIRI
|
9.0 | IC50 | 2 | — | |
LDZIHQWKUDOFTP
|
9.0 | IC50 | 5 | — | |
LKHRNKGUBSNVDM
|
9.0 | IC50 | 2 | — | |
MJBNLVZGJYYOOP
|
9.0 | IC50 | 5 | — | |
MPYUMMWCLQVMLG
|
9.0 | IC50 | 11 | — | |
NAWYNVJDAIYLPP
|
9.0 | IC50 | 2 | — | |
PTNPCFXETPRXSF
|
9.0 | IC50 | 3 | — | |
VLXIXYDIKYYMAQ
|
9.0 | IC50 | 7 | — | |
YOMVQFWXFWVVPY
|
9.0 | IC50 | 2 | — | |
YYQDOAWXLMOOHX
|
9.0 | IC50 | 2 | — | |
ZKWLKJSJNCHHNJ
|
9.0 | IC50 | 2 | — | |
BAPFBTJYCKDGNL
|
9.0 | IC50 | 5 | — | |
APZRUVKUOLBLPV
|
9.0 | IC50 | 2 | — | |
HRSOTZFHFDXFAE
|
9.0 | IC50 | 5 | — | |
LKMLECIRYJPQOC
|
9.0 | IC50 | 5 | — | |
AYPCWHSHCPRJCW
|
9.0 | IC50 | 2 | — | |
CBVNCWLIAXJKQI
|
9.0 | IC50 | 2 | — | |
CVQIAUMEBBKXIR
|
9.0 | IC50 | 2 | — | |
IMYLSIBTGYMGSC
|
9.0 | Kd | 3 | — | |
KCWGQPNZUSKGQY
|
9.0 | IC50 | 2 | — | |
PMWJNWXMNAKMHW
|
9.0 | IC50 | 5 | — | |
RREXRPSTGDCVNA
|
9.0 | Kd | 3 | — | |
UDMCHVHNRKDUMF
|
9.0 | IC50 | 3 | — | |
VQJKOCLQBPCETI
|
9.0 | IC50 | 2 | — | |
WBJVXOCKPDIYKG
|
9.0 | IC50 | 2 | — | |
ZGLWZSSPPSSMRB
|
8.9 | IC50 | 5 | — | |
FNJXQSFBTXMNDB
|
8.9 | IC50 | 4 | — | |
KMLOPXDUQAYXNF
|
8.9 | IC50 | 2 | — | |
AWNATJMQNZMYAX
|
8.9 | IC50 | 5 | — | |
BGAIPEGLRNYHJL
|
8.9 | IC50 | 2 | — | |
CGXQXIOHFLFFRH
|
8.9 | IC50 | 4 | — | |
GZRXWBJYUJUZNW
|
8.9 | IC50 | 3 | — | |
KPVANHBTOHTGQY
|
8.9 | IC50 | 2 | — | |
RRMREUMOGRRUAC
|
8.9 | Kd | 3 | — | |
SGTRNEIPZDPUOK
|
8.9 | IC50 | 2 | — | |
SJEVLHTYUBABDJ
|
8.9 | IC50 | 4 | — | |
STIKXRCJPIYNRT
|
8.9 | IC50 | 2 | — | |
UIUUIHADIPAKSK
|
8.9 | IC50 | 5 | — | |
XTLRUHNSWCKNBK
|
8.9 | IC50 | 5 | — | |
DDHPDOGCZLIDPA
|
8.9 | IC50 | 4 | — | |
PFOPEHMNVZBJHK
|
8.9 | IC50 | 2 | — | |
PFOPEHMNVZBJHK
|
8.9 | IC50 | 2 | — | |
XCAGIHJCPNUGAK
|
8.9 | IC50 | 2 | — | |
IGHUBVIQSUHAEU
|
8.9 | IC50 | 2 | — | |
LOVFMAWZNVTQTF
|
8.9 | IC50 | 2 | — | |
LYDRTKDNCXYTQA
|
8.9 | IC50 | 5 | — | |
NGGUKLWGYUVOPF
|
8.9 | IC50 | 2 | — | |
NVDKWZYTSONJAW
|
8.9 | IC50 | 2 | — | |
QECODAPTOHJSRN
|
8.9 | IC50 | 5 | — |